In an in vitro cellular cytotoxicity assay, this antibody displayed superior toxicity for CD133+/EGFRvIIIhigh glioma cells than for CD133+ or EGFRvIIIhigh cells alone and also decreased stem-like properties such as self-renewal. This evidence concerns the gene PROM1 and central nervous system cancer.